Abeona Therapeutics (ABEO) Revenue (Gross) (2021 - 2025)
Historic Revenue (Gross) for Abeona Therapeutics (ABEO) over the last 5 years, with Q3 2025 value amounting to $1.7 million.
- Abeona Therapeutics' Revenue (Gross) rose 4062.24% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 2687.85%. This contributed to the annual value of $4.2 million for FY2024, which is 10056.68% up from last year.
- Latest data reveals that Abeona Therapeutics reported Revenue (Gross) of $1.7 million as of Q3 2025, which was up 4062.24% from $1.0 million recorded in Q2 2025.
- Over the past 5 years, Abeona Therapeutics' Revenue (Gross) peaked at $1.7 million during Q3 2025, and registered a low of $5000.0 during Q4 2021.
- For the 5-year period, Abeona Therapeutics' Revenue (Gross) averaged around $636588.2, with its median value being $593000.0 (2023).
- Per our database at Business Quant, Abeona Therapeutics' Revenue (Gross) surged by 646000.0% in 2022 and then crashed by 1376.99% in 2025.
- Quarter analysis of 5 years shows Abeona Therapeutics' Revenue (Gross) stood at $5000.0 in 2021, then surged by 6460.0% to $328000.0 in 2022, then soared by 126.52% to $743000.0 in 2023, then soared by 37.69% to $1.0 million in 2024, then skyrocketed by 63.44% to $1.7 million in 2025.
- Its Revenue (Gross) was $1.7 million in Q3 2025, compared to $1.0 million in Q2 2025 and $1.3 million in Q1 2025.